Peter Greenleaf, chair of the board overseeing the $84 million InvestMaryland venture fund, is taking a CEO job with Massachusetts-based biotech company Histogenics.
Greenleaf, former president of MedImmune in Gaithersburg, will remain chairman of the InvestMaryland board, a four-year position, at the request of Governor Martin O’Malley.
Read more here.
Join the conversation!
Find news, events, jobs and people who share your interests on Technical.ly's open community Slack
Baltimore daily roundup: Film fest spotlights cinema's immersive frontier; over $1M for a wellness startup; $2B to rebuild the Key Bridge
Baltimore daily roundup: Key takeaways on the local tech ecosystem; a video editor's path to working with Keke Palmer; BCIT's new podcast
Baltimore daily roundup: 20 people building Baltimore's innovation community; a local startup's $15K win; the USMC's new tech office
